Medications for Carcinoma Breast Stage Iv

7 results
  • abraxane - paclitaxel injection, powder, lyophilized, for suspension

    (Paclitaxel)
    Abraxis Bioscience, Llc
    ABRAXANE treats metastatic breast cancer after prior chemotherapy failure, locally advanced or metastatic non-small cell lung cancer (first-line with carboplatin) in patients ineligible for surgery or radiation, and metastatic pancreatic adenocarcinoma (first-line with gemcitabine).
  • arimidex - anastrozole tablet

    (Anastrozole)
    Ani Pharmaceuticals, Inc.
    Arimidex is an aromatase inhibitor for postmenopausal women with breast cancer: adjuvant treatment of hormone receptor-positive early breast cancer; first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer; and second-line treatment of advanced breast cancer following tamoxifen therapy progression.
  • ixempra - ixabepilone

    (Ixabepilone)
    R-Pharm Us Operating, Llc
    Ixempra treats metastatic or locally advanced breast cancer: in combination with capecitabine for anthracycline- and taxane-resistant disease, or as monotherapy for tumors resistant to anthracyclines, taxanes, and capecitabine.
  • orserdu - elacestrant tablet, film coated

    (Elacestrant)
    Stemline Therapeutics, Inc.
    Orserdu treats ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer in postmenopausal women or adult men whose disease has progressed after at least one prior endocrine therapy.
  • perjeta - pertuzumab injection, solution, concentrate

    (Pertuzumab)
    Genentech, Inc.
    Perjeta is used with trastuzumab and chemotherapy to treat HER2-positive breast cancer in adults. Indicated for metastatic breast cancer without prior anti-HER2 therapy, neoadjuvant treatment of locally advanced or early-stage breast cancer, and adjuvant treatment of early breast cancer at high risk of recurrence.
  • phesgo - pertuzumab, trastuzumab, and hyaluronidase - zzxf injection, solution

    (Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf)
    Genentech, Inc.
    Phesgo (pertuzumab, trastuzumab, hyaluronidase) treats HER2-positive breast cancer in adults: neoadjuvant and adjuvant treatment with chemotherapy for early-stage breast cancer, and with docetaxel for metastatic breast cancer in patients who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
  • verzenio - abemaciclib tablet

    (Abemaciclib)
    Eli Lilly And Company
    Verzenio (abemaciclib) treats HR-positive, HER2-negative breast cancer in adults. Used with endocrine therapy for high-risk early breast cancer, with an aromatase inhibitor or fulvestrant for advanced/metastatic disease, or as monotherapy after prior endocrine therapy and chemotherapy in the metastatic setting.